Cytotoxic activity of the casein kinase 2 inhibitor CX-4945 against T-cell acute lymphoblastic leukemia: targeting the unfolded protein response signaling-Reference-Cited by-同舟云学术

Cytotoxic activity of the casein kinase 2 inhibitor CX-4945 against T-cell acute lymphoblastic leukemia: targeting the unfolded protein response signaling

Published:2013-11-20 Issue:3 Volume:28 Page:543-553
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Buontempo F,Orsini E,Martins L R,Antunes I,Lonetti A,Chiarini F,Tabellini G,Evangelisti C,Evangelisti C,Melchionda F,Pession A,Bertaina A,Locatelli F,McCubrey J A,Cappellini A,Barata J T,Martelli A M

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu2013349.pdf

Reference60 articles.

1. Pui CH, Robison LL, Look AT . Acute lymphoblastic leukaemia. Lancet 2008; 371: 1030–1043.

2. Van Vlierberghe P, Ferrando A . The molecular basis of T cell acute lymphoblastic leukemia. J Clin Invest 2012; 122: 3398–3406.

3. Jenkinson S, Koo K, Mansour MR, Goulden N, Vora A, Mitchell C et al. Impact of NOTCH1/FBXW7 mutations on outcome in pediatric T-cell acute lymphoblastic leukemia patients treated on the MRC UKALL 2003 trial. Leukemia 2013; 27: 41–47.

4. Blackburn JS, Liu S, Raiser DM, Martinez SA, Feng H, Meeker ND et al. Notch signaling expands a pre-malignant pool of T-cell acute lymphoblastic leukemia clones without affecting leukemia-propagating cell frequency. Leukemia 2012; 26: 2069–2078.

5. Lhermitte L, Ben Abdelali R, Villarese P, Bedjaoui N, Guillemot V, Trinquand A et al. Receptor kinase profiles identify a rationale for multitarget kinase inhibition in immature T-ALL. Leukemia 2013; 27: 305–314.

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CSNK2A1 confers gemcitabine resistance to pancreatic ductal adenocarcinoma via inducing autophagy;Cancer Letters;2024-03

2. Cancer selective cell death induction by a bivalent CK2 inhibitor targeting the ATP site and the allosteric αD pocket;iScience;2024-02

3. Is It Still Possible to Think about HSP70 as a Therapeutic Target in Onco-Hematological Diseases?;Biomolecules;2023-03-28

4. AB668, a novel highly selective protein kinase CK2 inhibitor with a distinct anti-tumor mechanism as compared to CX-4945 and SGC-CK2-1;2022-12-16

5. CK2 and the Hallmarks of Cancer;Biomedicines;2022-08-16